Press Releases

News

Roswell Park Researchers Take Center Stage at Meeting of Experts on Gynecologic Cancers

Members of Roswell Park Comprehensive Cancer Center’s senior leadership team, physician staff and fellows have been invited to present research findings and insights at the Society of Gynecologic Oncology (SGO) 50th Annual Meeting on Women’s Cancer. SGO is considered the premier specialty society for healthcare professionals focused on comprehensive treatment of gynecological cancers. The meeting runs March 16-19 in Honolulu, Hawaii.

Dr. Song Yao
News

Roswell Park Attracts $28.2M in Grants, Including $9.7M for Studies of Breast Cancer in African-Americans

A $6.6 million award from the National Cancer Institute (NCI) leads the latest slew of grants awarded to Roswell Park Comprehensive Cancer Center researchers. These awards totaling more than $28.2 million in new funding from federal agencies as well as nonprofit foundations and associations will enable critical investigations to help explain why an aggressive form of breast cancer is more common in African-American women, learn how cancer metastasizes and develops resistance to treatment, explore opportunities to enhance patients’ recovery following surgery and advance development of a pioneering immunotherapy involving engineered T cells.

News

Roswell Park Workforce Swells to Record Level With Latest Slate of Hires and Promotions

The team at Roswell Park Comprehensive Cancer Center has reached record levels, growing to a workforce of more than 3,500. The latest appointments announced by Roswell Park President and CEO Candace S. Johnson, PhD, and her senior leadership team mark a milestone for the 121-year-old cancer center, reflecting expansion across all areas of operations, from clinical care and education to new frontiers in cancer research.

News

Roswell Park Presentations at TCT 2019 Focus on Tools for Predicting Patient Outcomes

Particularly in the realm of cancer care, which can mean years of treatment and follow-up for patients, clinicians look to a number of tools and metrics to guide their decision-making regarding what, if any, treatment options and care approaches may be most effective for a particular patient. Roswell Park Comprehensive Cancer Center experts were invited to highlight ways to optimize these predictive strategies to improve both treatment and rehabilitation of patients undergoing hematopoietic stem cell transplantation, also known as bone marrow transplant, during the TCT/Transplantation and Cellular Therapy Meetings now underway in Houston, Texas.
News

Roswell Park Researchers Identify Protein That Contributes to Racial Disparities in Prostate Cancer

Cancer researchers have long known that prostate cancer tends to be more common, more aggressive and more resistant to existing treatments in African-Americans than in Caucasian-Americans, but they’re only beginning to understand why. A Roswell Park Comprehensive Cancer Center study published today points to cellular factors that appear to be driving these disparities — mitochondrial differences that prevent formation of the cancer-killing “death wheel” apoptosome protein complex — and proposes a strategy for overcoming these factors with new therapeutic targets.
News

Roswell Park Reports New Path to Overcoming Drug Resistance in HER2-Positive Breast Cancer

The HER2 protein, which encourages the growth of cancer cells, is present in about 20% of all breast cancers. While HER2-positive breast cancers tend to be very aggressive, today the prognosis is generally very good, thanks to the introduction of HER2 inhibitors such as trastuzumab (brand name Herceptin). However, not all HER2-positive breast cancers respond to existing HER2 inhibitors.